News Coverage 11.13.19 By: Marta Figueiredo Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests Related Announcement, From Bench to Fireside From NK Cell Biology to a Career in Breakthrough Science with Lewis Lanier, PhD Announcement, From Bench to Fireside Introducing: From Bench to Fireside Announcement PICI Network at #SITC23
Announcement, From Bench to Fireside From NK Cell Biology to a Career in Breakthrough Science with Lewis Lanier, PhD